NXGL
NEXGEL, Inc. [NXGL] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
NXGL Stock Summary
In the News
NXGL Financial details
Company Rating
-
Market Cap
19.16M
Income
-3.16M
Revenue
4.09M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
12
Optionable
No
Shortable
Yes
Earnings
09 May 2024
P/E
-5.73
Forward P/E
-
PEG
1.16
P/S
6.06
P/B
2.59
P/C
-
P/FCF
-5.47
Quick Ratio
2.69
Current Ratio
3.58
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0.56
EPS next Y
-
EPS next Q
-
EPS this Y
-49.09%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
31.95%
Revenue last 5Y
41.65%
Revenue Q/Q
-11.38%
EPS Q/Q
97.51%
-
-
-
-
SMA20
-2.01%
SMA50
-0.29%
SMA100
31.15%
Inst Own
-
Inst Trans
-
ROA
-26%
ROE
-39%
ROC
-0.37%
Gross Margin
14%
Oper. Margin
-86%
Profit Margin
-73%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
1.32-3.14
52W High
+10.67%
52W Low
+232%
RSI
44.28
Rel Volume
4.48
Avg Volume
23.07K
Volume
103.27K
Perf Week
1.53%
Perf Month
-5.41%
Perf Quarter
16.49%
Perf Half Y
25.76%
-
-
-
-
Beta
0.681
-
-
Volatility
0.15%, 0.16%
Prev Close
-7.78%
Price
3.32
Change
-7.52%
Company Profile
- Volume Average 23.07K
- Market Capitalization 19.16M
- Employee 12
- CEO Mr. Adam R. Levy
- Headquarters Langhorne,PA,US
- IPO Date 2021-12-22
-
Website
https://nexgel.com 
NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was founded in 1997 and is based in Langhorne, Pennsylvania.
